Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-8.59
↓ 54% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-5.59
Historical baseline
PeriodValueYoY Change
TTM-8.59+59.0%
2024-20.94-494.9%
2023-3.52-56.4%
2022-2.25+30.1%
2021-3.22-1.3%
2020-3.18-33.6%
2019-2.38-260.6%
2018-0.66-